NCT00378040

Brief Summary

It is hypothesized that patients with vascular disease are undertreated for modifiable risk factors, leading to increased morbidity and mortality in this population. The objective of this study is to develop a comprehensive database that will demonstrate the current adequacy of risk factor management in this high risk population, and that will provide needed guidance for future treatment options.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
800

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2004

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2004

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

September 15, 2006

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 19, 2006

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2006

Completed
9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

May 16, 2016

Status Verified

May 1, 2016

Enrollment Period

2.5 years

First QC Date

September 15, 2006

Last Update Submit

May 12, 2016

Conditions

Peripheral Vascular Disease

Eligibility Criteria

Age30 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Those with confirmend PAD

You may qualify if:

  • All patients who attend the Vascular Surgery Clinic at Toronto General Hospital, St. Michael's Hospital, and St. Joseph's Health Centre who have PAD, cerebrovascular disease (CBVD), or aneurysms will be eligible for this study. Patients who are currently enrolled in other clinical studies are eligible for this study; however proper adherence to the other study will take precedence over of the current proposal.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Toronto General Hospital

Toronto, Ontario, M5G 2C4, Canada

Location

MeSH Terms

Conditions

Peripheral Vascular Diseases

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Officials

  • Thomas Lindsay, M.D

    Toronto General Hospital, University Health Network

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Surgery

Study Record Dates

First Submitted

September 15, 2006

First Posted

September 19, 2006

Study Start

June 1, 2004

Primary Completion

December 1, 2006

Study Completion

December 1, 2015

Last Updated

May 16, 2016

Record last verified: 2016-05

Data Sharing

IPD Sharing
Will share

See JAMA Surgery 2016 epublished First Author Dr M Hussain

Locations

CA(1)